<?xml version="1.0" encoding="UTF-8"?>
<p>Hepatitis C virus (HCV) affects approximately 170 million people worldwide; It is also being a major cause of end-stage liver disease leading to liver transplantation [
 <xref rid="B1" ref-type="bibr">1</xref>, 
 <xref rid="B2" ref-type="bibr">2</xref>]. The prevalence of HCV infection in patients with chronic kidney disease (CKD) exceeds that in the general population [
 <xref rid="B3" ref-type="bibr">3</xref>]. In the past, blood transfusion has played a major role in the transmission of HCV to patients under chronic hemodialysis [
 <xref rid="B4" ref-type="bibr">4</xref>]. There has been a noticeable decrease in HCV infection among these patients, however, after the introduction of regular screening for HCV and the use of erythropoietin [
 <xref rid="B5" ref-type="bibr">5</xref>].
</p>
